[Brain injury, immunity and infections].
Infections are a major cause of death and morbidity after acute injury of the central nervous system (CNS). Acute lesions of the CNS alter immune homeostasis contributing to the development of immunosuppression (IS), and making the bed of the infection. IS results in a decreased phagocytic functions of neutrophils and macrophages as well as monocyte deactivation (decreased capacity of antigen presentation to lymphocytes). The immune abnormalities occur very quickly and may last for weeks. The neurovegetative system is closely connected to the secondary lymphoid organs where cells of innate immunity receive information from injured organs inducing the long lasting adaptive immune response (immune synapse). The sympathetic system is critically involved in the IS through production of anti-inflammatory mediators like interleukin-10. This may prove important as all types of acute injury of the CNS can lead to direct damage to sympathetic centers. Specialized units of care for ischemic stroke, taking into account the risk of infection related to the IS, have improved the prognosis until 18th month after the initial damage of the SNC. It is now well recognized that the improved long-term prognosis is related with the secondary prevention of recurrent ischaemia as well as aggressive management of pulmonary infections. A better understanding of the pathophysiology of IS can be considered in the near future, opening the door to immunomodulatory therapeutic trials.
Service d'anesthésie réanimation, hôpital Hôtel-Dieu, CHU de Nantes, 1, place Alexis-Ricordeau, 44093 Nantes cedex 1, France.
A
A
Roquilly
C
C
Lejus
K
K
Asehnoune
D056704:Adaptive Immunity; D001930:Brain Injuries / Q000150:complications* / Q000276:immunology* / Q000628:therapy; D002545:Brain Ischemia / Q000276:immunology / Q000503:physiopathology; D002494:Central Nervous System Infections / Q000209:etiology* / Q000276:immunology* / Q000628:therapy; D006801:Humans; D007154:Immune System Diseases / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D007111:Immunity, Cellular / Q000502:physiology